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ASYMPTOMATIC INTESTINAL MICROSPORIDIOSIS IN
A HUMAN IMMUNODEFICIENCY VIRUS- 
SERONEGATIVE, IMMUNOCOMPETENT
ZAMBIAN CHILD
In recent years there has been increasing attention to 
microsporidial infection in humans. Microsporidia are obli­
gate intracellular protozoan parasites tha t infect a wide 
variety of lower animals. Four genera (Enterocytozoon, En- 
cephalitozoon, Pleistophora  and Nosema) have been identified 
inhuman microsporidiosis.1 Most symptomatic infections are 
found in immunocompromised patients.2 This concerns
mainly HIV-infected persons, in whom microsporidia are a 
frequent cause of diarrhea, biliary illness and occasionally 
systemic infection.
Various studies have been carried out in Africa investigat­
ing intestinal microsporidial infection in children. In a group 
of 106 children in H arare (Zimbabwe) with symptoms of 
persistent diarrhea, of whom 18 were confirmed to be HIV- 
seropositive, Enterocytozoon bieneusi infection could not be 
detected in any of the fecal samples.3 A study in Niger showed
8 of 990 children to have intestinal i?. bieneusi infection, from 
which 6 were reported to have diarrhea.4 A study in Kilifi 
(Kenya) showed no intestinal microsporidial infection in a 
group of 16 marasmic children and 32 children with kwash­
iorkor; a to tal of 5 children in this study were HIV- 
seropositive (RW Sauer we in, unpublished results).
In immunocompetent persons microsporidiosis is limited to 
case reports and includes four patients with corneal stroma 
infection, of which two were caused by Nosema and two were 
of undetermined Microsporidium  species.5 E . bieneusi infec­
tion in an immunocompetent adult has been reported by 
Sandfort et al.6; this was an HIV-seronegative adult with 
acute, self-limited traveller’s diarrhea, whose CD4+ cell count 
and plasma immunoglobulin values were normal. A case of 
self-limited traveller’s diarrhea in  an immunocompetent HIV- 
seronegative child with intestinal infection with E. bieneusi 
and Cryptosporidium parvum  was recently presented by 
Sobottka et al.7 We report a case of asymptomatic intestinal 
E, bieneusi infection in a HIV-seronegative, immunocompe­
tent Zambian child.
M e th o d s  a n d  case  r e p o r t .  In  a population-based survey 
conducted in Samfya District, Zambia, in 1994, we examined 
stool samples from 176 rural children for microsporidia. 
Before entrance in the study informed consent was obtained 
from the  parents or guardians of these children. Single fresh 
stool samples were collected and stored for 1 to 8 weeks a t 4°C 
with 100 julof 0.01% azide, before examination. The samples 
were examined for spores of microsporidia using the Uvitex 
2B® fluorescence method.8 Serum samples were collected to 
examine serologic HIV status.
One of 176 stool samples contained spores of-E. bieneusif as 
confirmed by electron microscopy. The child was a 7-month- 
old 8.0-kg boy in good nutritional status. The mother reported 
th a t  the boy had no history of diarrhea in the previous 2 
weeks. At the Tropical Diseases Research Centre in Ndola- 
Zambia, three more stool samples were routinely examined 
for ova and cysts, including Ziehl-Neelsen stain for oocysts of 
Cryptosporidium , all with negative results. Laboratory inves­
tigations showed normal results, with a hemoglobin of 8.5 g/dl 
and serum concentrations of albumin and C-reactive protein 
of 44 g/1 and 5 mg/1, respectively. The child was HIV- 
seronegative (HIV1/HIV2 Cambridge Biotech Recombigen 
ELISA® and HrVl/HIV2 IMX® test from Abbott), and serum 
immunoglobulin concentrations (IgG 11.32 g/1, IgM 2.06 g/1 
and IgA 0.45 g/1) showed no indication of immunodeficiency. 
In the total study group of 176 children, only 1 subject was 
HIV-positive.
Nine months later another stool sample was obtained from 
this child th a t  was negative for spores of microsporidia. By 
th a t time the boy was 16 months old and still in a good 
nutritional status (body weight, 9.7 kg). The mother gave no 
history of frequent or longstanding diarrhea in  her child since 
the previous visit. Recently when the child reached the age of
2 years and 4 months, plasma was collected and again found 
to be HIV-negative (HIV1/HIV2 Cambridge Biotech Recombi­
gen ELISA®).
D iscussion . Based on its relatively high prevalence in 
HIV-positive persons, it has been suggested th a t  E. bieneusi
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may be a natural parasite of humans that is missed in routine 
stool examination, and clinically manifest only in severely 
immunocompromised people.1 However, in one study the 
prevalence of intestinal microsporidia was not significantly 
different between HIV-infected persons with or without diar­
rhea.9 We report intestinal E. bieneusi infection in the ab­
sence of clinical symptoms in an HIV-seronegative, immuno­
competent child. Thus carriage of E . bieneusi has been 
demonstrated to occur in HIV-infected individuals, but im­
portantly our study shows that carriage of E. bieneusi can 
also occur in asymptomatic immunocompetent individuals.
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MUMPS INFECTION COMPLICATED BY TRANSIENT
HYPERINSULINEMIC HYPOGLYCEMIA
Mumps is a viral infection usually characterized by the 
development of parotitis. Several complications have been 
reported in the literature, including orchitis, oophoritis, mas­
titis,1 meningoencephalitis,2 deafness,3 arthritis,4 nephritis5 
and diabetes mellitus.6 It has been postulated that mumps 
virus has a trophism for the pancreas that produces injury to 
the islet cells resulting in diabetes.6,7 However, to our knowl­
edge hyperinsulinemic hypoglycemia has not been docu­
mented in patients with mumps. We describe a case and 
speculation regarding the possible pathophysiology.
Case report. An 11-year-old girl was brought to our 
hospital because of sudden development of dizziness, head­
ache, cold sweating and drowsiness. She had had mild fever 
and painful swelling of the right parotid gland for 3 days 
before admission. The initial blood glucose value was 35 mg/dl 
and the serum amylase was 534 IU/L Cerebrospinal fluid 
examination showed a white blood cell count of 3/mm3 which 
were all lymphocytes, a protein concentration of 65 mg/dl and 
a glucose value of 25 mg/dl. She recovered consciousness 
within seconds after intravenous infusion of 10% glucose- 
water, and her blood glucose concentration was maintained 
between 60 and 95 mg/dl. On the next day after discontinuing 
the glucose infusion for 3 h, lethargy developed and the blood 
glucose value was 34 mg/dl with a serum insulin concentra­
tion of 19.9 /xIU/ml (normal <10 /xIU/ml; for sugar <50 
mg/dl), The diagnosis of mumps was proved by a positive 
mumps IgM antibody (enzyme-linked immunosorbent assay, 
Medac) and 1:16 complement-fixing antibodies to both the S 
and V antigens (BioWhittaker). Mumps infection associated 
with hyperinsulinemic hypoglycemia was considered the 
most likely diagnosis. Attempts to discontinue the glucose 
infusion failed for the next 3 days because of the appearance 
of drowsiness, after which the infusions were stopped. Two 
weeks after the episode after an overnight fast for 9 h, the 
blood glucose level was 65 mg/dl and the serum insulin value 
was 0.32 ¿iIU/ml, She has been followed for 4 years without 
recurrence of hypoglycemia or evidence of diabetes. Her 
family refused further check of the mumps titers.
Discussion. The most common clinical presentations of 
mumps infection in children are fever and painful parotid 
swelling. Several complications have been reported, including 
orchitis, oophoritis, mastitis,1 meningoencephalitis,2 deaf­
ness,3 nephritis6 and arthritis.4 Rarely fatal cases have been 
reported,8 usually with late complications such as nephritis9 
and central nervous system infection.10 Diabetes mellitus 
after mumps was documented in 1834 by Strang (see Hin- 
den11). Fatal diabetes occurred in an infant whose mother 
developed mumps at the time of delivery. At autopsy signs of 
chronic pancreatitis were found,7 which could explain the 
cause of diabetes.
Our patient developed transient hyperinsulinemic hypo­
glycemia, which to our knowledge has not been previously 
documented in a patient with mumps. Two explanations, 
trophism of the mumps virus for the pancreas and a limited 
increase of serum interleukin-1, are possible. Trophism for 
the pancreas has been postulated as the cause of diabetes 
mellitus following mumps.6,7 It was possible that our patient 
developed a limited degree of islet cell destruction, which 
caused an acute and transient surge of insulin. Because 
damage to the islet cells was limited, diabetes mellitus did not 
develop.
Interleukin-1, a proinflammatory mediator, can induce 
hypoglycemia in three ways. The first is its anorectic effect.12 
The second is increased synthesis of glucose transporters, 
thus increasing intracellular glucose concentration.13 Finally
